| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/ARCHDISCHILD-2015-308924 |
| P698 | PubMed publication ID | 26289063 |
| P50 | author | Jonathan Craig | Q38591193 |
| Nicholas Larkins | Q40602055 | ||
| P2093 | author name string | Siah Kim | |
| Elisabeth Hodson | |||
| P2860 | cites work | Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 |
| Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial | Q33648228 | ||
| Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial | Q34497269 | ||
| A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment | Q34836338 | ||
| Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature | Q35059138 | ||
| Nephrotic syndrome in childhood. | Q35207868 | ||
| Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials. | Q35266925 | ||
| Clinical trial of focal segmental glomerulosclerosis in children and young adults | Q35837532 | ||
| Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial | Q36003160 | ||
| Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis | Q36190565 | ||
| Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome | Q36509322 | ||
| Evaluation and management of steroid-sensitive nephrotic syndrome | Q37107065 | ||
| Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome | Q37202763 | ||
| Epidemiology and predictors of end-stage renal disease in Taiwanese children with idiopathic nephrotic syndrome | Q37234203 | ||
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome | Q37670299 | ||
| Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. | Q38050961 | ||
| Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). | Q39581963 | ||
| Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome | Q42261957 | ||
| Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome | Q43092145 | ||
| Levamisole in steroid-sensitive nephrotic syndrome of childhood: the lost paradise? | Q45066117 | ||
| Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome | Q45355102 | ||
| Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial | Q46096920 | ||
| Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome | Q46486654 | ||
| Fatal pulmonary fibrosis after rituximab administration | Q47935891 | ||
| Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. | Q51749985 | ||
| Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. | Q52862093 | ||
| Corticosteroids for the initial episode of steroid-sensitive nephrotic syndrome | Q59167429 | ||
| Predictors of remission and relapse in idiopathic nephrotic syndrome: a prospective cohort study | Q59167474 | ||
| Rituximab for childhood-onset nephrotic syndrome | Q59167484 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nephrotic syndrome | Q504790 |
| P304 | page(s) | 404-408 | |
| P577 | publication date | 2015-08-19 | |
| P1433 | published in | Archives of Disease in Childhood | Q4787296 |
| P1476 | title | Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children | |
| P478 | volume | 101 |
| Q41714358 | Advances in paediatrics in 2016: current practices and challenges in allergy, autoimmune diseases, cardiology, endocrinology, gastroenterology, infectious diseases, neonatology, nephrology, neurology, nutrition, pulmonology |
| Q53702610 | Calcineurin inhibitors and nephrotoxicity in children. |
| Q38867651 | Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells |
| Q90198384 | Hsp90 inhibition aggravates adriamycin-induced podocyte injury through intrinsic apoptosis pathway |
| Q38815449 | Immunology of idiopathic nephrotic syndrome |
| Q92816853 | Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects |
| Q92118365 | Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation |
| Q64999527 | Plasma Zonulin Levels in Childhood Nephrotic Syndrome. |
| Q64997913 | Predictors of frequent relapsing and steroid-dependent nephrotic syndrome in children. |
| Q41906685 | REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study. |
| Q42424215 | The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective |
Search more.